002038.SZ · 双鹭药业
China A-shares · RS rating 17 · As of 2026-10-14
| Price | 5.44 CNY |
|---|---|
| 1-day change | -1.3% |
| RS rating (overall / 1M / 3M / 12M) | 17 / 38 / 39 / 32 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 16 / 32 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -17.0% |
| Distance from 52-week high | +39.4% |
| Market cap (USD) | $885.0M |